01) and 6-to-12-hour-dwell (p < 0.02) of PD patients with oral pyridoxamine compared with PD patients with this website no oral pyridoxamine. Conclusion: Pyridoxamine is a potent candidate of a protective agent against progressive deterioration of peritoneal function in PD patients. CHANG JER-MING1, CHEN SZU-CHIA1,2, CHEN HUNG-CHUN1 1Division of Nephrology, Department of Internal Medicine, Kaohsiung Medical University Hospital; 2Department of Internal Medicine, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University Introduction: Neurological complications are prevalent, and contribute

largely to the morbidity and mortality in patients with renal failure. Quantitative

sensory testing (QST) is a reliable test of large and small fiber sensory modalities, documented well by the American Diabetes Association endorsement of QST in 1992 as a valid test in epidemiologic studies and drug trials of diabetic neuropathy.QST can assess and quantify sensory nerve function noninvasively. QST has potential as a neurophysiologic tool. Using QST, sensory deficits may be quantified and the data can be used in parametric Neratinib ic50 statistical analysis. Previous study showed thermal sensation was abnormal in 30% of 64 non-diabetic hemodialysis patients, which was a much higher prevalence than that which has previously been reported. However, the role of small fiber neuropathy remained

uncertain in peritoneal dialysis (PD) population. We evaluated the prevalence and associated risk factors of abnormal thermal sensation in PD. Methods: This study enrolled Lumacaftor molecular weight 19 persistent PD patients. Thermal sensitivity was assessed by QST. Demographic and medical data including age, gender and comorbid conditions were obtained from medical records or interviews with patients. Statistical analysis was performed using SPSS 17.0 for windows (SPSS Inc. Chicago, USA). Results: The mean age of the 19 patients was 51.3 ± 10.7 years. The median of PD duration was 68.4 months. Thermal sensation was abnormal in 68.4% (13/19) of the patients. Compared with patients with normal thermal sensation, patients with abnormal thermal sensation were found to have older age (54.9 ± 7.6 vs. 43.3 ± 12.7 years; P = 0.023). Conclusion: Our study showed a high prevalence of abnormal thermal sensation in PD. Old age was associated with abnormal thermal sensation. The limited patient number restricted our study power. Future prospective studies were needed to survey the long-term outcomes in large PD population.